Reflections on the etiology of structural birth defects: Established teratogens and risk factors

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 103, Issue 8, 2015, Pages 652-655

  Feldkamp, Marcia L ^a   Botto, Lorenzo D ^a   Carey, John C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Birth defects; Congenital structural defects; Etiology; Malformations; Risk factors; Teratogens

Indexed keywords

AMFEBUTAMONE; ATRAZINE; CAFFEINE; CLOMIFENE CITRATE; COCAINE; ENDOCRINE DISRUPTOR; FOLIC ACID ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; METHAMPHETAMINE; OPIATE; PESTICIDE; PHENTERMINE PLUS TOPIRAMATE; PHYTOESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SOLVENT; TERATOGENIC AGENT; TOPIRAMATE; TRIHALOMETHANE; VENLAFAXINE;

AIR POLLUTION; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CONGENITAL MALFORMATION; EDITORIAL; ENVIRONMENTAL FACTOR; HUMAN; HYPERTENSION; HYPERTHERMIA; INFERTILITY; INFERTILITY THERAPY; NUTRITION; OBESITY; OCCUPATION; PASSIVE SMOKING; PREGNANCY DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; THYROID DISEASE; VIRUS INFECTION; ABNORMALITIES, DRUG-INDUCED; CONGENITAL ABNORMALITIES; FEMALE; PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; PREGNANCY; RISK FACTORS; TERATOGENS;

EID: 84939258916     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23392     Document Type: Editorial

References (13)

1. Balken E, Leen-Mitchell M, Martinez LP, Robertson JA. 2011. Environmental causes of birth defects. In: Rudolph's pediatrics, 22nd ed., chapter 183, New York: McGraw-Hill. pp. 732-739.
2. Brent RL. 2004. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 113:957-968.
3. Carey JC, Martinez L, Balken E, et al. 2009. Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines. Birth Defects Res A Clin Mol Teratol 85:63-68.
4. Chambers CD, Braddock SR, Briggs GG, et al. 2001. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 64:252-261.
5. Correa A, Marcinkevage J. 2013. Pregnancy obesity and the risk of birth defects: an update. Nutr Rev Suppl 1:S68-S77.
6. Davies MJ, Moore VM, Wilson KJ, et al. 2012. Reproductive technologies and the risk of birth defects. N Engl J Med 366:1803-1813.
7. Fraser FC. 1980. The William Allan Memorial Award Address: evolution of a palatable multifactorial threshold model. Am J Hum Genet 32:796-813.
8. Holmes LB. 2011. Human teratogens: update 2010. Birth Defects Res A Clin Mol Teratol 91:1-7.
9. Lin AE, Rasmussen SA, Scheuerle A. 2009. Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles. Birth Defects Res A Clin Mol Teratol 85:69-75.
10. Mascarenhas MN, Flaxman SR, Boerma T et al. 2012. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 9:e1001356.
11. Mitchell AA, Gilboa SM, Werler MM, et al. 2011. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 205:51.
12. Okun N, Sierra S. 2014. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can 36:64-83.
13. Shepard TH. 1994. Proof of human teratogenicity. Teratology 50:97-98.